Summary: The Centers for Medicare & Medicaid Services modified its coverage policy for PET perfusion of the heart, effective May 15, 2026. Here's what billing teams need to know before claims start moving through adjudication under the updated rules.
CMS PET heart perfusion coverage policy changes don't happen often — and when they do, they tend to ripple across cardiology and nuclear medicine billing fast. This modification touches one of the more clinically and financially significant imaging categories in Medicare billing. The policy does not list specific CPT or HCPCS codes in the available data, but PET perfusion of the heart billing is well-established territory with a defined code set your team should already be tracking. Pull that list now and treat this update as a trigger to audit your current workflows before May 15, 2026.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | PET for Perfusion of the Heart |
| Policy Code | N/A |
| Change Type | Modified |
| Effective Date | May 15, 2026 |
| Impact Level | High |
| Specialties Affected | Cardiology, Nuclear Medicine, Radiology, Cardiac Imaging Centers |
| Key Action | Audit your current PET myocardial perfusion claims workflow against updated CMS criteria before May 15, 2026 |
CMS PET Heart Perfusion Coverage Criteria and Medical Necessity Requirements 2026
CMS has a long history with PET myocardial perfusion imaging — and that history matters here. The agency has moved this technology from experimental to covered status over time, with medical necessity criteria that tie coverage tightly to clinical indication. This modification continues that pattern.
The core question in any CMS PET heart perfusion coverage policy review is whether the imaging is being used to guide a real clinical decision — not just to confirm one already made. CMS requires that perfusion imaging be ordered for a patient where the diagnosis is genuinely uncertain, or where the result will change management. That threshold is not new, but modifications to coverage policy often tighten or clarify how it's applied.
Whether CMS PET heart perfusion is covered under Medicare depends on the patient's documented clinical condition and what question the imaging is answering. Your documentation must show the ordering physician's rationale. A generic order with a chest pain ICD-10 code attached is not sufficient if the clinical record doesn't support why PET was chosen over a less expensive modality.
Prior authorization is not universally required for PET myocardial perfusion under CMS fee-for-service Medicare — but Medicare Advantage plans operate under their own prior auth rules, and this CMS policy modification may prompt MA plans to update their own criteria in parallel. If your volume skews toward Medicare Advantage, check with each plan separately before the effective date of May 15, 2026.
Medical necessity documentation needs to do real work here. The ordering physician's notes should tie the PET order to a specific clinical gap — such as inconclusive stress testing, coronary artery disease risk stratification, or viability assessment before revascularization. Each of those indications carries a different documentation burden, and your billing team should know which one applies to each claim before it goes out the door.
CMS PET Heart Perfusion Exclusions and Non-Covered Indications
CMS does not cover PET perfusion of the heart as a routine screening tool. If a patient has no symptoms and no documented risk factors that rise to the level of clinical concern, PET perfusion is not a covered service under Medicare. That's not ambiguous — it's categorical.
Repeated PET perfusion studies without documented clinical change in the patient's condition are also a denial risk. CMS expects each study to answer a discrete clinical question. If the previous PET result is on record and nothing has changed, a new order needs a very clear justification in the documentation. Absent that, expect a claim denial.
Coverage policy under CMS also excludes PET perfusion when an alternative, lower-cost modality would provide the same clinical information. This is the medical necessity bar that trips up the most claims. Your documentation needs to show not just why PET was ordered, but why SPECT or stress echo wasn't sufficient. If the ordering physician didn't document that distinction, go back to the record before billing.
Coverage Indications at a Glance
The specific policy data available for this modification does not include a detailed, indication-by-indication breakdown. The table below reflects established CMS coverage positions for PET myocardial perfusion imaging, based on the agency's longstanding National Coverage Determination framework. Treat this as a working reference — not a substitute for reviewing the full updated policy at the effective date.
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Diagnosis and management of patients with known or suspected coronary artery disease | Covered | Not specified in available policy data | Medical necessity documentation required; must show imaging will change management |
| Viability assessment prior to revascularization | Covered | Not specified in available policy data | Strong clinical documentation required; prior cardiac workup should be on record |
| Risk stratification in patients with inconclusive stress testing | Covered | Not specified in available policy data | Document why prior testing was inconclusive and how PET answers the clinical question |
| Routine cardiac screening in asymptomatic patients | Not Covered | Not specified in available policy data | No symptoms, no covered indication |
| Repeat perfusion imaging without documented clinical change | Not Covered | Not specified in available policy data | Each study must answer a discrete new clinical question |
| PET perfusion when SPECT or other modality would suffice | Not Covered | Not specified in available policy data | Must document why alternative modalities are insufficient |
CMS PET Heart Perfusion Billing Guidelines and Action Items 2026
Here's what to do before May 15, 2026. These are not suggestions — they're the actions that separate a clean claim from a denial.
| # | Action Item |
|---|---|
| 1 | Pull every PET myocardial perfusion claim from the last 90 days and audit the documentation. Look for orders where the physician's rationale is thin or missing. If those claims are still in your AR, add documentation now. If they've already been submitted and paid, flag the pattern — because CMS audits often follow policy modifications. |
| 2 | Update your charge capture workflow to include a documentation checkpoint. Before a PET heart perfusion claim moves to billing, someone on your team should confirm that the record includes the ordering physician's clinical rationale, the patient's relevant history, and a statement about why alternative modalities were not used. Build this into your pre-bill review, not your denial management queue. |
| 3 | Check your Medicare Advantage contracts separately. The CMS modification covers traditional Medicare fee-for-service. MA plans set their own prior authorization requirements and coverage criteria. Contact each MA payer your practice works with and ask whether they're updating their PET perfusion policies in response to the CMS change. Do this before May 15, 2026 — not after your first denial. |
| 4 | Train your ordering physicians on documentation specifics. The most common failure point in PET perfusion billing is not the code — it's the note. Physicians need to document the specific clinical question the PET is answering, why other modalities don't address it, and how the result will change management. A 10-minute conversation with your cardiology or nuclear medicine team about documentation standards is worth more than any denial appeal. |
| 5 | Review your ICD-10 code pairing practices. Diagnosis codes must match the clinical scenario described in the physician's documentation. A chest pain code on a viability assessment claim will raise questions. Make sure your coding team understands the clinical distinction between each covered indication and is selecting diagnosis codes that reflect the actual clinical picture — not just the patient's presenting complaint. |
| 6 | Talk to your compliance officer before the effective date if you have high PET perfusion volume. If PET myocardial perfusion imaging is a significant revenue line for your practice or facility, the risk exposure here is real. A compliance review of your current process — documentation, coding, billing, and denial patterns — is worth doing now rather than after CMS starts auditing under the modified policy. If you're not sure how this applies to your specific patient mix or payer mix, loop in your billing consultant before May 15, 2026. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for PET Heart Perfusion Under This Policy
The available policy data for this CMS modification does not list specific CPT, HCPCS, or ICD-10 codes. Do not treat that gap as permission to guess.
PET myocardial perfusion imaging has a well-established code set in general use, but applying codes to this specific policy update without confirmation from the full policy document creates real denial and audit risk. Your coding team should pull the complete policy from CMS directly — the source URL for this modification is https://app.payerpolicy.org/p/cms/292-v2 — and confirm the exact code set covered under the updated criteria before billing claims after May 15, 2026.
If your MAC has issued a Local Coverage Determination that intersects with this CMS national policy, that LCD may include code-level guidance. Check with your Medicare Administrative Contractor for regional specifics. MACs sometimes publish billing articles alongside national policy modifications that give you the code-level detail the national document omits.
Reimbursement rates for PET myocardial perfusion imaging fall under the Medicare Physician Fee Schedule and the Hospital Outpatient Prospective Payment System, depending on your billing setting. A policy modification at the coverage level doesn't automatically change the fee schedule — but it can shift which claims get paid at all. That's the financial exposure your team needs to manage here.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.